Guideline Updates in Nontuberculous Mycobacterial Lung Disease Management

Read expert faculty member summaries of guideline updates in the diagnosis, monitoring, and treatment of patients with nontuberculous mycobacterial lung disease (NTM-LD).
Keira A. Cohen, MD
Program Director
person default
David E. Griffith, MD
Princy N. Kumar, MD, FIDSA, MACP
Format: Microsoft PowerPoint (.ppt)
File Size: 822 KB
Released: November 8, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Insmed Incorporated

Related Content

Expert commentary on trends in the management of HABP/VABP from Dr Keith S. Kaye and Clinical Care Options (CCO)

Keith S. Kaye, MD, MPH Released: January 24, 2022

Expert commentary on addressing barriers to vaccine uptake in older individuals, from Dr Barbara Resnick and Clinical Care Options (CCO)

Barbara Resnick, PhD, CRNP Released: January 12, 2022

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: January 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings